| SPC1 | SPC2 | VPC1 | VPC1 |
---|
BMI,Kg/m2 | Pearson Correlation | .160 | -.492 | .398 | -.222 |
p-value | ns | .001 | .006 | ns |
WC,cm | Pearson Correlation | .154 | -.530 | .433 | -.178 |
p-value | ns | .000 | .003 | ns |
HC,cm | Pearson Correlation | .158 | -.549 | .440 | -.281 |
p-value | ns | .000 | .002 | .059 |
WHR,- | Pearson Correlation | .032 | -.104 | .113 | .237 |
p-value | ns | ns | ns | ns |
WHtR,- | Pearson Correlation | .182 | -.579 | .369 | -.219 |
p-value | ns | .000 | .012 | ns |
BAI,- | Pearson Correlation | .025 | -.129 | .118 | -.380 |
p-value | ns | ns | ns | .009 |
VAI,- | Pearson Correlation | .131 | -.445 | .355 | -.311 |
p-value | ns | .002 | .015 | .035 |
LAP,- | Pearson Correlation | .203 | -.615 | .335 | -.305 |
p-value | ns | .000 | .023 | .039 |
AVI,- | Pearson Correlation | .140 | -.429 | .120 | -.035 |
p-value | ns | .003 | ns | ns |
WWI,- | Pearson Correlation | .163 | -.554 | .329 | -.145 |
p-value | ns | .000 | .026 | ns |
CI,- | Pearson Correlation | .154 | -.531 | .434 | -.183 |
p-value | ns | .000 | .003 | ns |
HOMA-IR, | Pearson Correlation | .202 | -.374 | .387 | -.168 |
p-value | ns | .011 | .008 | ns |
Fasting Insulin, µU/mL | Pearson Correlation | .301 | -.280 | .306 | -.190 |
p-value | .042 | .060 | .038 | .206 |
- Four patterns were identified using principal component analysis for adipogenic and lipogenic genes in subcutaneous (SPC1 and SPC2) and visceral (VPC1 and VPC2) adipose tissue.
- SPC1 was characterized by high transcript levels of SREBP1c, PPARγ, FAS, and ACC.
- SPC2 was associated with C/EBPα and LXR α mRNA expression.
- VPC1 was characterized by transcript levels of SREBP1c, FAS, and ACC.
- VPC2 was identified by C/EBPα, LXR α, and PPARγ mRNA expression.
- BMI, body mass index; VAI, visceral adiposity index; BAI, body adiposity index; VI, abdominal volume index; WWI, weight-adjusted waist index; CI; conicity index; WC, waist circumference; HC, hip circumference; WHR, waist-to-hip ratio; WHtR, Waist to Height Ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AMH, anti-mullerian hormone; HOMA-IR, homeostasis model assessment of insulin resistance; HbA1c, hemoglobin A1C; ns,non-significant